These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 20015152

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Sarcoidosis induced by therapy with pegylated interferon alfa-2a].
    Bruch-Gerharz D, Reifenberger J.
    Hautarzt; 2006 Apr; 57(4):317-35. PubMed ID: 16523277
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Antiviral therapy of patients with chronic hepatitis C with normal level of aminotransferases].
    Lopukhova NL.
    Eksp Klin Gastroenterol; 2007 Apr; (4):146-52. PubMed ID: 18409502
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Alopecia universalis: a rare side effect seen on chronic hepatitis C treatment with peg-IFN and ribavirin.
    Demirturk N, Aykin N, Demirdal T, Cevik F.
    Eur J Dermatol; 2006 Apr; 16(5):579-80. PubMed ID: 17101483
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pegylated interferon alfa-2a and ribavirin treatment for recurrent hepatitis C: role of steatosis and body mass index.
    Testino G, Gentile R, Ansaldi F, Borro P, Ravetti G, Icardi G, Sumberaz A.
    Panminerva Med; 2009 Jun; 51(2):135-6. PubMed ID: 19776716
    [No Abstract] [Full Text] [Related]

  • 15. [Thrombocytopenia in patients with chronic hepatitis C].
    Bakulin IG, Sharabanov AS, Moliarenko EV, Iakovleva EV.
    Eksp Klin Gastroenterol; 2010 Jun; (5):52-8, 60; quiz 59, 122. PubMed ID: 20731135
    [Abstract] [Full Text] [Related]

  • 16. [Cutaneous reactions induced by pegylated-interferon plus ribavirin combination therapy in a patient with chronic hepatitis C].
    Enjoji M, Dainichi T, Gondo H, Urabe K.
    Fukuoka Igaku Zasshi; 2007 Sep; 98(9):353-6. PubMed ID: 17974079
    [Abstract] [Full Text] [Related]

  • 17. Development of sarcoidosis during interferon alpha 2b and ribavirin combination therapy for chronic hepatitis C--a case report and review of the literature.
    Bolukbas C, Bolukbas FF, Kebdir T, Canayaz L, Dalay AR, Kilic G, Ovunc O.
    Acta Gastroenterol Belg; 2005 Sep; 68(4):432-4. PubMed ID: 16432996
    [Abstract] [Full Text] [Related]

  • 18. Interferon for hepatitis C patients with psychiatric disorders.
    Rifai MA, Bozorg B, Rosenstein DL.
    Am J Psychiatry; 2004 Dec; 161(12):2331-2; author reply 2332-4. PubMed ID: 15569919
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.